Social Media Intervention for Type 1 Diabetes

Overseen By Faisal Malik, MD

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: Seattle Children's Hospital

Disqualifiers: Pregnancy, Severe comorbidities, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 6 months

60 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to evaluate the feasibility of a social media intervention to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to receive diabetes education and peer support over Instagram or to usual outpatient diabetes care. Researchers will assess whether the social media intervention is feasible. In addition, the study team will also explore and compare changes in glucose levels and person-reported outcomes between the two groups.

Research Team

Faisal S Malik, MD, MSHS

Principal Investigator

Seattle Children's Hospital

Eligibility Criteria

This trial is for English-speaking adolescents with type 1 diabetes who have had it for at least a year, an HbA1c level over 7.0%, and use a Dexcom CGM device. They must be able to use Instagram and complete surveys but can't join if they're pregnant, wards of the state, or have severe health conditions that affect daily life.

Inclusion Criteria

I passed the Social Media Preference Screener.

I have been diagnosed with type 1 diabetes for over a year.

I have a personal Instagram account.

Exclusion Criteria

I have severe health conditions that affect my daily life significantly.

I am pregnant and understand my diabetes care will change.

Patient is a ward of the state

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive diabetes education and peer support over Instagram in addition to usual care

6 months

Ongoing virtual engagement via Instagram

Follow-up

Participants are monitored for changes in glucose levels and person-reported outcomes

6 months

Treatment Details

Interventions

• Social Media

Trial Overview The study tests whether using Instagram for diabetes education and peer support helps manage type 1 diabetes in adolescents compared to standard care. Participants are randomly chosen to either get this new social media-based intervention or continue their usual outpatient care.

Participant Groups

Group I: Social Media Intervention Experimental Treatment 1 Intervention

In addition to receiving usual care, participants enrolled in the social media arm will receive diabetes education and support over the course of 6 months by following the study team's Instagram page and engaging with the study team and other adolescent participants on Instagram.

Group II: Usual Care Active Control 1 Intervention

Usual care reflects the standard treatment currently provided to adolescents living with type 1 diabetes. Every adolescent with diabetes is cared for by a team of diabetes specialists which includes a provider (MD, Physician Assistant and/or Nurse Practitioner), registered nurse, nutritionist and social worker. Adolescents with type 1 diabetes are seen by their multidisciplinary team approximately every 3 months. In addition, they have access to their multidisciplinary care team via telephone and/or MyChart communication as often as is necessary between clinic visits.

Who Is Running the Clinical Trial?

Seattle Children's Hospital

Lead Sponsor

Trials

319

Recruited

5,232,000+